Developer of hypertension drug. The company develops and produces drug, oral drug agents and treatments for pulmonary arterial hypertension.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Navitas Assets (Cicletanine Business)‘s full profile, request access.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Navitas Assets (Cicletanine Business)‘s full profile, request access.
Request a free trial